reported that apigenin (a CK2 inhibitor) suppressed the transcriptional activity of several signal pathways, such as AKT, ERK, STAT3 and NF-κB and downregulated the expression of several anti-apoptotic proteins, to induce tumor cells apoptosis in multiple myeloma cells (61). This evidence concerns the gene NFKB1 and AL amyloidosis.